INTERLEUKIN-8-NEUTRALIZING MONOCLONAL ANTIBODY BMS-986253 PLUS NIVOLUMAB (NIVO) IN BIOMARKER-ENRICHED, PRIMARILY ANTI-PD-(L)1-EXPERIENCED PATIENTS WITH ADVANCED CANCER: INITIAL PHASE 1 RESULTS-MedSci.cn

INTERLEUKIN-8-NEUTRALIZING MONOCLONAL ANTIBODY BMS-986253 PLUS NIVOLUMAB (NIVO) IN BIOMARKER-ENRICHED, PRIMARILY ANTI-PD-(L)1-EXPERIENCED PATIENTS WITH ADVANCED CANCER: INITIAL PHASE 1 RESULTS

Davar, D; Simonelli, M; Gutierrez, M; Calvo, E; Melear, J; Piha-Paul, S; Richards, D; Dallos, M; Parameswaran, J; Kumar, V; Zhao, XC; Dutta, S; Melero, I

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020; 8 (): A239

科室
- - 订阅+
  - 更多科室
工具
服务